AstraZeneca Tagrisso gets USFDA priority review for unresectable, Stage III EGFR-mutated lung cancer Ruchika Sharma11 Jun 2024 11:39 AM ISTAstraZeneca's supplemental New Drug Application (sNDA) for TAGRISSO (osimertinib) has been accepted and granted Priority Review in the US for the...
Roche Alecensa gets European Commission nod as targeted adjuvant treatment for ALK-positive early-stage lung cancer Ruchika Sharma10 Jun 2024 10:00 AM ISTBasel: Roche announced today that the European Commission has approved Alecensa (alectinib) monotherapy, as adjuvant treatment following tumour...
Low-fat diet associated with lower risk of lung cancer especially in smokers: Study Dr Riya Dave7 Jun 2024 9:00 PM ISTResearchers have found that adherence to a low-fat diet (LFD) can significantly reduce the risk of lung cancer in middle-aged and older adults. A...
AstraZeneca Tagrisso, chemotherapy recommended for approval in EU by CHMP for EGFR-mutated advanced lung cancer Ruchika Sharma5 Jun 2024 2:00 PM ISTCambridge: AstraZeneca's Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been recommended for...
Medical Bulletin 22/ May/ 2024 Anshika Mishra22 May 2024 3:00 PM ISTHere are the top medical news for the day:Study Finds microplastics in human testicular tissueIn a study published in the journal Toxicological...
Study links low-fat diets to reduced lung cancer risk in older adults Anshika Mishra22 May 2024 8:15 AM ISTIn a recent study published in The Journal of Nutrition, Health and Aging, researchers investigated the associations between dietary patterns and lung...
CT volumetric imaging enhances lung function assessment in lung cancer patients, claims study Medha Baranwal2 May 2024 11:30 PM ISTChina: In a groundbreaking development in thoracic oncology, the clinical application of computed tomographic (CT) volumetric imaging is poised to...
JnJ gets positive CHMP opinion for Rybrevant, chemotherapy combo for first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations Ruchika Sharma28 April 2024 12:30 PM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
Roche Alecensa gets USFDA nod for ALK-positive early-stage lung cancer Ruchika Sharma20 April 2024 12:05 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following...
Shilpa Medicare marketing partner unveils Pemrydi Rtu in US Ruchika Sharma20 April 2024 11:17 AM ISTPEMRYDI RTU is a novel ready-to-use injection which eliminates the need for refrigeration or reconstitution and dilution for administration to the...
Medicover Cancer Institute performs minimal access surgery to treat lung cancer Kajal Rajput9 April 2024 9:45 AM ISTHyderabad: In the field of lung cancer treatment, Medicover Cancer Institute, under the expert guidance of Dr Pavan Kumar Jonmada is introducing a...
Merck begins phase 3 trial of MK-1084, Keytruda combo for first-line treatment of certain patients with Metastatic Non-Small Cell Lung Cancer Ruchika Sharma6 April 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced it has initiated a Phase 3 clinical trial evaluating MK-1084,...
